Destination Wealth Management Biogen Inc. Transaction History

Destination Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $62,405 - $69,993	-287 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$219.29 - $241.72 $657 - $725	-3 Reduced 1.03%	287 $67,000
Q1 2019 May 01, 2019	BUY	$216.71 - $338.96 $650 - $1,016	3 Added 1.05%	290 $69,000
Q4 2018 Feb 05, 2019	SELL	$278.5 - $352.75 $1,114 - $1,411	-4 Reduced 1.37%	287 $86,000
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $1,174 - $1,535	4 Added 1.39%	291 $103,000
Q1 2018 Apr 05, 2018	BUY	$260.13 - $367.91 $74,657 - $105,590	287 New	287 $79,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Destination Wealth Management with notifications on news.